Board of directors

Paul Van Dun

Managing Director LRD, the n°1 TTO in Europe

Rudy Dekeyser

Managing Partner LSP-Health Economics Fund and founder VIB, a top 3 life science institute world-wide

Tine Bekaert

Sr. Investment Manager PMV Lifesciences, the do and dare company shaping the future of the Flemish economy

Goedele Ertveldt

Investment Manager, Federale Participatie- en Investeringsmaatschappij

David Devigne

Investment Director at Korys, a diversified, triple bottom-line family holding with life sciences one of its focus areas


Gerard Griffioen

CSO Drug Discovery. Gerard obtained his PhD degree in 1996 at the Free University of Amsterdam where he pursued his research interests in the fields of Biochemistry and Molecular Biology by studying molecular mechanisms involved in controlling gene transcription.

He subsequently held research positions at the University of Vienna (Austria) and the University of Leuven (Belgium).

Jim Van heusden

Interim CEO reMYND, Managing Director bioskills

Clinical Advisory Board Alzheimer

Prof. Dr. Kaj Blennow

Professor at the Department of Psychiatry and Neurochemistry, University of Gothenburg.

Prof. Dr. Jeffrey Cummings

Professor of Neurology and Psychiatry; Director Alzheimer Disease Research Center David Geffen School of Medicine at UCLA; member on the GRECC Advisory Committee.

Prof. Dr. Henrik Zetterberg

Professor at the Institute of Neuroscience and Physiology and Head of the Department of Psychiatry and Neurochemistry, University of Gothenburg.